<DOC>
	<DOCNO>NCT00238940</DOCNO>
	<brief_summary>This extension study consider allow patient treat EC-MPS collect information long-term safety drug .</brief_summary>
	<brief_title>Extension Study Enteric-coated Mycophenolate Sodium Combination With Full Dose Reduced Dose Cyclosporine Microemulsion Patients With de Novo Kidney Transplants</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion/ Exclusion criterion All patient complete study CERL080A2405DE01 willing continue treatment ECMPS . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Renal transplantation , Enteric-Coated Mycophenolate Sodium ( EC-MPS )</keyword>
</DOC>